PET/MR examination

I want to make a private appointment

Go to

State-of-the-art diagnostics in the fight against lifestyle diseases

Thanks to the use of the innovative mMR scanner from Siemens, we can offer you examinations that are unique on a national scale. PET/MR is a diagnostic examination during which magnetic resonance imaging (MRI) and positron emission tomography (PET) of the whole body (from the top of the head to the middle of the thighs) are performed simultaneously.

The PET MR method uses fully diagnostic magnetic resonance, in the case of our scanner with an induction power of up to 3T. This allows for an accurate anatomical image of tissues and organs.

As a result, the PET/MR method provides information on the structure, function and metabolism of organs and systems in the patient’s body. Positron emission tomography with magnetic resonance imaging is extremely useful in the process of early detection and treatment of many diseases and provides a number of benefits for our patients. Comparison of the PET/MR technique to the classic PET/CT examinations can be found in the Comparison of PET examinations tab.

We are proud of our reputation as a leader in PET/CT and PET/MR. Our team of highly qualified doctors and medical technologists work with passion and commitment to provide our patients with the best possible care.

  • Step by step

    Price list PET/MR

    5 steps to get your PET/MR result

  • Step 1


    Make an appointment for a free qualifying visit:

    phone: 85 500 10 25,


    in person: Żurawia 71a, Bialystok.

  • Step 2

    Free qualification for the examination

    Qualification for your convenience can be done by phone, and our specialists will contact you at the agreed time. You will always be asked to provide the necessary medical documentation.

  • Step 3

    Arranging the date of the examination

    Patients who are qualified by the doctor for the examination set its date together with the registration. You will be asked to make an advance payment for the purchase of the radiopharmaceutical that will be imported for you.

  • Step 4

    Performing the examination

    Patients are scheduled for a specific hour and do not need to wait for the examination longer than necessary. Before administering the radiopharmaceutical, the patient is examined by a doctor.

  • Step 5

    Collect examination results

    The examination result described by two specialist doctors is available after a few days. The whole period from the moment of the patient’s decision to receiving the examination results does not exceed 10 days.

Application of PET/MR examinations

  • detection, assessment of malignancy, stage of advancement (local and distant metastases), assessment of response to treatment and diagnostics in the case of suspected tumor recurrence based on their metabolic activity and image in magnetic resonance imaging,
  • assessment of the activity of neoplastic lesions in order to plan radiotherapy,
  • assessment of tumor activity to indicate the place for biopsy,
  • assessment of response to chemo-, radio- and immunotherapy in oncological patients,
  • detection, staging and assessment of brain tumor recurrence – significantly higher diagnostic sensitivity than PET-CT,
  • imaging of head and neck tumors, e.g. cancer of the tongue, oral cavity, larynx – higher spatial resolution in relation to the PET / CT technique
  • diagnostics of lung diseases, including: lung tumors, lung metastases – sensitivity comparable to PET-CT,
  • diagnosis and assessment of mediastinal tumors,
  • detection and assessment of the stage of pleural mesothelioma,
  • assessment of the malignancy and advancement of breast tumors, including lymph nodes and distant metastases,
  • assessment of the location of active inflammatory lesions in the course of inflammatory diseases (inflammatory bowel disease, sarcoidosis, vasculitis and others),
  • diagnosis of focal changes in the liver,
  • diagnosis of focal lesions in the skeletal system,
  • exclusion/confirmation of the metastatic nature of the lesions, searching for the primary focus,
  • assessment of the advancement and response to treatment of malignant tumors of the skeletal system,
  • abdominal cancers, differential diagnosis, assessment of the advancement of lesions, suspicion of recurrence,
  • hepatocellular carcinoma, gallbladder cancer, cholangiocarcinoma, kidney cancer – assessment of the degree of malignancy, advancement stage, suspicion of recurrence, assessment of response to treatment,
  • pancreatic tumors, assessment of the nature of the changes and stage of advancement,
  • gastrointestinal cancers (stomach, small intestine, large intestine, including rectum) – assessment of the degree of malignancy, advancement stage, response to treatment and suspicion of recurrence,
  • prostate cancer, assessment of the primary lesion, search for recurrence foci and assessment of the advancement of changes,
  • diagnostics, staging and recurrence of gynecological cancers in women in the pelvic area: ovarian cancer, endometrial cancer, cervical cancer,
  • cancers of the musculoskeletal system: assessment of the stage of the disease, diagnosis of metastases/recurrences, assessment of response to treatment,
  • malignant melanoma – the examination enables the detection of metastases (usually subcutaneous, to the bones, liver and brain) and evaluation of the effectiveness of treatment,
  • lymphomas and other haematological diseases – assessment of the stage of the disease, recurrence, selection of the appropriate method of treatment and assessment of response to treatment,
  • searching for the primary tumor focus,
  • searching for foci of inflammation, fever of unknown etiology,
  • location of parathyroid adenoma,
  • suspected thyroid cancer recurrence, with a negative I-131 scintigraphy examination,
  • diagnosis of neurodegenerative diseases, dementia – e.g. Alzheimer’s disease, differential diagnosis of fronto-temporal dementia (FTD) and Alzheimer’s disease (AD),
  • location of epilepsy foci,
  • assessment of myocardial viability.



We do not perform examinations in pregnant women and in people who have implanted cochlear implants, metallic elements that cannot be imaged in magnetic resonance, or there is no appropriate documentation to assess the patient’s safety.



PET/MR examination may be performed under specific conditions (always to the decision of the doctor supervising the examination, based on medical documentation):

  • claustrophobia,
  • stents, vascular clips, stent grafts, cardioverter/defibrillator, pacemakers, neurostimulators, orthopedic stabilization, orthodontic appliances, dental implants.

Price list for PET/MR scans (gross price in PLN)

Type of examinationRadiopharmaceuticalExamination priceThe cost of examination under anesthesia
Breast examination18F-FDG3,200.004,200.00
Whole body scan18F-FDG6,500.008,000.00
Whole body scan18F-Fluorocholine6,500.008,000.00
Whole body scan68Ga-PSMA7,500.009,000.00
Whole body scan68Ga-DOTA-TATE8,500.0010,000.00
Whole body scan68Ga-DOTA-TOC8,500.0010,000.00
Head examination18F-FET (Tyrosine)18,500.0020,000.00
Head examination18F Florbetaben (FBB)11,000.0012,000.00

Price list for combined PET/CT and PET/MR scans (gross price in PLN)

Type of examinationRadiopharmaceuticalExamination priceThe cost of examination under anesthesia
Whole body PET/CT scan + breast examination PET/MR18F-FDG5,500.007,000.00
Whole body scan18F-FDG7,600.009,150.00
Whole body scan18F-Fluorocholine8,100.009,650.00
Whole body scan68Ga-PSMA9,600.0011,150.00
Whole body scan68Ga-DOTA-TATE9,600.0011,150.00
Whole body scan68Ga-DOTA-TOC9,600.0011,150.00
Whole body scan18F-PSMA16,500.0018,050.00
Head examination18F-FET (Tyrosine)20,000.0021,550.00
Head examination18F-Florbetaben (FBB)12,000.0013,550.00
Whole-body PET/MR without tracer costsThe appropriate PET/CT examination3,500.00-
PET/MR of one region without tracer costsThe appropriate PET/CT examination1,500.00-
  • What is the difference between PET/MR and PET/CT

    Detailed information on the differences between these examinations is presented on a dedicated subpage comparing examinations. The PET/MR examination is a multiparametric examination, which means two examinations in one, i.e. positron emission tomography examination and fully diagnostic 3-Tesla magnetic resonance imaging. By overlaying the images, the patient and their doctor receive more information that can help in making a diagnosis. In the case of PET/CT examinations, computed tomography is only auxiliary and is not fully diagnostic. In addition, the PET/MR examination is characterized by a much lower dose of ionizing radiation. For more information, please visit the subpage.
  • Could everyone perform PET MRI examination?

    Each time a decision about qualifying a patient is made by a medical doctor based on a medical history. According to our standards, patients receive a free qualification of a doctor specializing in nuclear medicine. It should be remembered that each PET MRI examination is associated with exposure to ionizing radiation (although the exposure is minimal, ionizing radiation should be used only in justified cases). In such cases, the ALARA principle is used – as low as reasonably achievable (as small doses of ionizing radiation as reasonably possible). Always diagnostic or therapeutic benefits obtained using an isotope must overcome the risk of exposure to ionizing radiation. Therefore, our specialists will evaluate and indicate the most beneficial diagnostic tests from the point of view of the patient's health.
  • Is exposure to ionizing radiation in the PET MRI test is high?

    No, because the doses of radiopharmaceuticals are selected individually for each patient (calculated on the basis of body weight – 4 MBq / 1 kg of body mass). We give the lowest possible doses of radiotracers, but sufficient to achieve the expected diagnostic benefits. When exposed to ionizing radiation and the selection of isotope doses, the ALARA principle is used – as low as reasonably achievable (as small doses as reasonably possible). In the case of PET / MRI studies, there is no additional exposure from magnetic resonance to ionizing radiation (in contrast to hybrid tests using PET / CT computed tomography). In addition, the unbound isotope is quickly excreted from the body mainly in the urine. The 18F isotope used for the study has a relatively short physical half-life – 110 minutes, i.e. after that time, half of the given radiotracer activity in the body becomes 220 min. there is already ¼ of the initial amount and so up to the complete decomposition of the radiotracer. According to the principles of radiation protection, it is assumed that after 10 half-lives (T1/2), the marker disintegrates completely.
  • Can I drive after the test?

    Yes, after the examination without general anesthesia, you can perform all daily activities, this also includes driving a car. Just remember to drink water (about 5 glasses) to help flush out the radioactive substance.
  • Do I have to stay in the hospital overnight for an examination under general anesthesia?

    There is no need. A PET/MR examination under general anesthesia is performed in the presence of an anaesthesiology specialist, however, it is still an outpatient examination, which means that the patient goes home on the same day.
  • Can the examination cause claustrophobia?

    This is possible because being in a confined space can cause anxiety or discomfort. To prevent this, you can ask your doctor to give you a sedative or perform an examination under general anesthesia.
  • How long will I be a source of radiation?

    Very low levels of radiation last for about 6-12 hours, up to a maximum of 24 hours.